#1 Clinical Trials Search in Europe

Dexmedetomidine Hydrochloride

Dexmedetomidine Hydrochloride, also known by the brand name Precedex, is being studied in various clinical trials for its potential benefits in sedation and pain management. This article will explore how this drug is being investigated for use in different patient populations and medical procedures, from pediatric intensive care to surgical settings. We’ll look at its effects on sedation levels, pain control, and overall patient outcomes based on recent clinical research.

Table of Contents

What is Dexmedetomidine?

Dexmedetomidine hydrochloride, also known simply as dexmedetomidine or by the brand name Precedex, is a medication used primarily for sedation in medical settings[2][3]. It belongs to a class of drugs called alpha-2 adrenergic agonists, which means it works on specific receptors in the brain to produce its effects[4].

Uses of Dexmedetomidine

Dexmedetomidine is used in various medical scenarios, including:

  • Sedation in intensive care units (ICUs): It’s used to keep patients calm and comfortable while on mechanical ventilation (a machine that helps with breathing)[5].
  • Procedural sedation: It’s used to sedate patients for various medical procedures, especially in children[1].
  • Anesthesia adjunct: It’s sometimes used alongside other anesthesia medications during surgeries[6].
  • Management of agitated delirium: It’s being studied for use in patients with severe confusion and agitation, particularly in palliative care settings[7].

How Dexmedetomidine Works

Dexmedetomidine works by activating alpha-2 receptors in the brain. This action has several effects:

  • Sedation: It produces a calm, sleepy state without causing deep unconsciousness. Patients can often still be awakened and respond to commands[7].
  • Pain relief: It has some pain-relieving (analgesic) properties, which can help reduce the need for other pain medications[6].
  • Anxiety reduction: It can help reduce anxiety and stress[1].

How Dexmedetomidine is Administered

Dexmedetomidine is typically given in one of these ways:

  • Intravenous (IV) infusion: This is the most common method, where the medication is given slowly through a vein[5].
  • Intranasal administration: In some cases, especially for children, it may be given as a nasal spray[8].
  • Subcutaneous infusion: In certain situations, it may be given under the skin[7].

The dosage and duration of administration depend on the specific use and the patient’s individual characteristics.

Benefits of Dexmedetomidine

Dexmedetomidine offers several potential benefits:

  • Rousable sedation: Unlike some other sedatives, patients on dexmedetomidine can often be awakened easily, which can be beneficial in certain medical situations[7].
  • Reduced need for opioids: It can help reduce the amount of opioid pain medication needed, which may decrease side effects associated with opioids[6].
  • Minimal respiratory depression: Unlike some other sedatives, dexmedetomidine doesn’t significantly suppress breathing[7].
  • Potential anti-inflammatory effects: Some research suggests it may help reduce inflammation in the body[9].

Potential Side Effects

Like all medications, dexmedetomidine can cause side effects. Common ones include:

  • Bradycardia: Slowing of the heart rate[10].
  • Hypotension: Low blood pressure[10].
  • Nausea and vomiting[5].
  • Dry mouth[10].

In most cases, these side effects are manageable and resolve when the medication is stopped. However, patients are closely monitored when receiving dexmedetomidine, especially for changes in heart rate and blood pressure.

Ongoing Research

Researchers are continually studying dexmedetomidine to understand its full potential. Current areas of investigation include:

  • Use in pediatric patients: Studies are looking at its safety and effectiveness in children for various procedures[1][2].
  • Management of agitated delirium: Its potential in helping patients with severe confusion and agitation is being explored[7].
  • Pain management after surgery: Its role in reducing pain and opioid use after operations is under investigation[6].
  • Immunomodulatory effects: Some studies are looking at how it might affect the immune system[9].

As research continues, we may discover new uses and benefits of dexmedetomidine in medical care.

Aspect Details
Primary Uses in Trials Sedation in pediatric ICU, procedural sedation, post-operative pain management, cough suppression during anesthesia emergence
Administration Methods Intravenous infusion, intranasal administration (in some trials)
Dosage Ranges Varies by age and use; typically 0.2-1.4 μg/kg/hr for infusions
Patient Populations Infants (45 weeks corrected gestational age) to adults; focus on pediatric and surgical patients
Potential Benefits Improved sedation control, reduced need for other medications, decreased coughing, possible anti-inflammatory effects
Monitored Side Effects Changes in heart rate, blood pressure, respiratory function; potential withdrawal symptoms; skin reactions at infusion sites
Key Outcome Measures Sedation effectiveness, pain control, hemodynamic stability, recovery time, patient comfort

FAQ

  • What is Dexmedetomidine Hydrochloride used for in clinical trials? Dexmedetomidine Hydrochloride is being studied for various uses, including sedation in pediatric intensive care units, sedation during medical procedures, pain management after surgery, and reducing coughing during anesthesia emergence.
  • How is Dexmedetomidine administered in these trials? The drug is typically administered intravenously, with dosages and infusion rates varying based on the patient's age, weight, and the specific medical context. Some trials are also exploring intranasal administration for certain procedures.
  • What are the potential benefits of using Dexmedetomidine? Potential benefits being studied include improved sedation control, reduced need for other sedatives or pain medications, decreased coughing during recovery from anesthesia, and possible anti-inflammatory effects.
  • Are there any side effects being monitored in these trials? Yes, researchers are monitoring for side effects such as changes in heart rate, blood pressure, and respiratory function. They're also looking at potential withdrawal symptoms and skin reactions at infusion sites.
  • Who is being included in these clinical trials? The trials include various patient groups, from infants as young as 45 weeks corrected gestational age to adults. Specific studies focus on pediatric patients, surgical patients, and those requiring intensive care.

Ongoing Clinical Trials on Dexmedetomidine Hydrochloride

  • Study on the Effects of Low-Dose Sevoflurane, Dexmedetomidine, and Remifentanil Anesthesia on Neurodevelopment in Children Under 2 Undergoing Long Surgeries

    Recruiting

    1 1 1 1
    Investigated drugs:
    Italy

Glossary

  • Dexmedetomidine Hydrochloride: A medication that acts as a sedative and pain reliever. It works by affecting certain receptors in the brain to produce calming effects without causing significant breathing problems.
  • Sedation: The process of making a patient calm or sleepy, often used during medical procedures or in intensive care settings to reduce anxiety and discomfort.
  • Intensive Care Unit (ICU): A specialized hospital department that provides continuous monitoring and advanced life support for critically ill patients.
  • Anesthesia: Medications used to prevent pain during surgery or other medical procedures. It can cause a loss of sensation or consciousness.
  • Intubation: The process of inserting a tube through the mouth and into the airway. This is done to help a patient breathe during surgery or when on a ventilator.
  • Extubation: The removal of the breathing tube (endotracheal tube) from a patient's airway.
  • Pharmacokinetics: The study of how a drug moves through the body, including how it's absorbed, distributed, metabolized, and eliminated.
  • Pharmacodynamics: The study of how a drug affects the body, including its mechanism of action and the relationship between drug concentration and effect.
  • Adverse Drug Reaction (ADR): An unwanted or harmful reaction experienced following the use of a medication.
  • Rescue Medication: Additional medication given when the primary treatment is not adequately controlling symptoms or achieving the desired effect.

References

  1. https://clinicaltrials.gov/study/NCT03290625
  2. https://clinicaltrials.gov/study/NCT06085573
  3. https://clinicaltrials.gov/study/NCT04040439
  4. https://clinicaltrials.gov/study/NCT03312413
  5. https://clinicaltrials.gov/study/NCT04027829
  6. https://clinicaltrials.gov/study/NCT03596424
  7. https://clinicaltrials.gov/study/NCT04824144
  8. https://clinicaltrials.gov/study/NCT03530371
  9. https://clinicaltrials.gov/study/NCT05489900
  10. https://clinicaltrials.gov/study/NCT02757625